Belinda J. Thomas
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Artificial Intelligence Will Boost Repurposing of Registered Compounds for Respiratory and Other Indications.
Journal: Respirology (Carlton, Vic.)
Published: August 19, 2025
Generation of a novel lung fibrosis model using precision-cut lung slices from transgenic TGFβ1 mice.
Journal: American journal of physiology. Cell physiology
Published: July 21, 2025
Lung-specific TGFβ overexpression increases airway fibrosis and airway contractility in transgenic mice.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: June 30, 2025
Pirfenidone Mitigates Transforming Growth Factor-β-induced Inflammation after Viral Infection.
Journal: American journal of respiratory cell and molecular biology
Published: April 16, 2025
AI as a tool to repurpose existing compounds for respiratory indications.
Journal: The Lancet. Respiratory medicine
Published: April 15, 2025
The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells.
Journal: BioFactors (Oxford, England)
Published: February 12, 2024
Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection.
Journal: Nature communications
Published: January 02, 2023
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease.
Journal: American journal of respiratory cell and molecular biology
Published: January 23, 2020
TGF-β: Master regulator of inflammation and fibrosis.
Journal: Respirology (Carlton, Vic.)
Published: September 10, 2018
Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses.
Journal: mBio
Published: October 05, 2017
Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung.
Journal: Scientific reports
Published: June 02, 2017
Last Updated: 09/26/2026